Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Melanoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 298Magnetic Resonance Spectroscopy 245pembrolizumab 224Carboplatin 183Biopsy 158Cyclophosphamide 149Cisplatin 145Paclitaxel 129Nivolumab 125Gemcitabine 114Bevacizumab 112Radiotherapy 92Dexamethasone 85Pemetrexed 81atezolizumab 80fludarabine 77Fluorouracil 75Doxorubicin 75Docetaxel 73Radiation 69Leucovorin 69Rituximab 68Prednisone 66Oxaliplatin 66venetoclax 65durvalumab 60Vincristine 59Cetuximab 56130-nm albumin-bound paclitaxel 56Immunoglobulin G 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ketones × 30 days × Clear all
NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Suspended
60 enrolled
DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡